Latest Articles
Mapping Human Uterine Disorders Through Single-Cell Transcriptomics.
Disruptions in uterine tissue function contribute to disorders such as endometriosis, adenomyosis, endometrial cancer, and fibroids, which all significantly impact health and fertility. Advances in transcriptomics, particularly single-cell RNA sequencing, …
Published: Jan. 21, 2025, midnight
Management of Diaphragmatic Central Tendon Plays an Important Role in the Surgical Treatment of Catamenial Pneumothorax: A Case Report - Cureus
Management of Diaphragmatic Central Tendon Plays an Important Role in the Surgical Treatment of Catamenial Pneumothorax: A Case Report Cureus
Published: Jan. 20, 2025, 9:41 p.m.
Dr Vetter on the Role of Trial Inclusion Criteria on Coverage for Pembrolizumab- and Dostarlimab-Based Regimens in Endometrial Cancer - OncLive
Dr Vetter on the Role of Trial Inclusion Criteria on Coverage for Pembrolizumab- and Dostarlimab-Based Regimens in Endometrial Cancer OncLive
Published: Jan. 20, 2025, 9:34 p.m.
Dostarlimab Combo Earns Expanded European Approval in Endometrial Cancer - Cancer Network
Dostarlimab Combo Earns Expanded European Approval in Endometrial Cancer Cancer Network
Published: Jan. 20, 2025, 5:08 p.m.
Endometriosis: A Chronic Disease - MSN
Endometriosis: A Chronic Disease MSN
Published: Jan. 20, 2025, 3:22 p.m.
GSK’s Jemperli combination approved by EC for expanded endometrial cancer use - PMLiVE
GSK’s Jemperli combination approved by EC for expanded endometrial cancer use PMLiVE
Published: Jan. 20, 2025, 12:33 p.m.
Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment - Femtech Insider
Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment Femtech Insider
Published: Jan. 20, 2025, 10:56 a.m.
Gesynta Pharma Raises SEK 304 Million to Advance Novel Endometriosis Treatment - beQuoted
Gesynta Pharma Raises SEK 304 Million to Advance Novel Endometriosis Treatment beQuoted
Published: Jan. 20, 2025, 8:21 a.m.
GSK’s Jemperli gains EU approval for advanced endometrial cancer treatment - DirectorsTalk Interviews
GSK’s Jemperli gains EU approval for advanced endometrial cancer treatment DirectorsTalk Interviews
Published: Jan. 20, 2025, 7:28 a.m.
GSK’s Jemperli Gains Expanded EU Approval for Broader Endometrial Cancer Treatment - TipRanks
GSK’s Jemperli Gains Expanded EU Approval for Broader Endometrial Cancer Treatment TipRanks
Published: Jan. 20, 2025, 7:19 a.m.
Link copied to clipboard!